Evidence map›Paper›PMID 40949046›Full record

ArticleRSC advances2025

Structure-property relationships in tris(2-amino-5-methylpyridinium) hexabromobismuthate monohydrate with a focus on optical and electrical behavior for optoelectronics applications.

Rima Altalib, Imen Ibrahmi, Arafet Ghoudi, Sami Znaidia, Walid Rekik, Jerome Lhoste, Abderrazek Oueslati

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rima AltalibLaboratory of Spectroscopic Characterization and Optical Materials, Faculty of Sciences, University of Sfax BP 1171 3000 Sfax Tunisia arafetghoudi199@gmail.com.ORCID https://orcid.org/0009-0004-5266-9854
Imen IbrahmiLaboratory of Spectroscopic Characterization and Optical Materials, Faculty of Sciences, University of Sfax BP 1171 3000 Sfax Tunisia arafetghoudi199@gmail.com.
Arafet GhoudiLaboratory of Spectroscopic Characterization and Optical Materials, Faculty of Sciences, University of Sfax BP 1171 3000 Sfax Tunisia arafetghoudi199@gmail.com.ORCID https://orcid.org/0000-0002-2120-5043
Sami ZnaidiaLaboratoire de recherche (LR 18ES19), Synthese Asymetrique et Ingenierie Moleculaire de Materiaux Organiques our L'electroniques Organiques, Facult des sciences de Monastir 5000 Tunisia.
Walid RekikLaboratory Physical-Chemistry of Solid State, Chemistry Department, Faculty of Sciences of Sfax, University of Sfax BP 1171 3000 Sfax Tunisia.
Jerome LhosteInstitut des Molécules et Matériaux du Mans (IMMM) - UMR-6283 CNRS, Le Mans Université Avenue Olivier Messiaen F-72085 Le Mans Cedex 9 France.ORCID https://orcid.org/0000-0002-4570-6459
Abderrazek OueslatiLaboratory of Spectroscopic Characterization and Optical Materials, Faculty of Sciences, University of Sfax BP 1171 3000 Sfax Tunisia arafetghoudi199@gmail.com.ORCID https://orcid.org/0000-0002-3221-3401

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hybrid compound (C

Identifiers

PMID40949046
PMCPMC12424129

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.